Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Epithalon

    Longevity & Cellular Health

    Status
    Preclinical, , not approved for human use
    Evidence

    Small human studies, no aging outcome, graded on 2 research benches

    Epithalon (also spelled Epitalon, sequence Ala-Glu-Asp-Gly / AEDG) is a synthetic tetrapeptide designed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in the 1980s as a short-chain analog of epithalamin, a peptide extract of bovine pineal gland.

    Reviewed

    01Overview

    What Epithalon is

    It is the most-studied "longevity peptide" in the Russian peer-reviewed literature, with over 30 years of published work on telomerase activation, telomere lengthening, melatonin restoration, and life-span extension in rodents.

    Read the full overviewShow less

    The core biology is three-fold:

    • Telomerase activation in somatic cells — Khavinson and colleagues reported that AEDG induced hTERT expression, telomerase activity and telomere elongation in telomerase-negative human fetal fibroblasts (PMID: 12937682), and that treated cells made 10 extra divisions, reaching passage 44 against 34 in the control (PMID: 15455129).
    • Restoration of pineal melatonin secretion — In aged rats and in elderly humans, epithalon restored the nocturnal melatonin peak that declines with pineal calcification, improving circadian amplitude and sleep architecture ([Anisimov et al., 2003]).
    • Direct chromatin binding (epigenetic): fluorescence and nuclear-penetration studies show that labeled AEDG enters the nucleus of HeLa cells and binds single- and double-stranded deoxyribooligonucleotides, preferring CNG and CAG sequences and discriminating cytosine methylation status (PMID: 22117547).

    Critical evidence-quality caveat: Unlike BPC-157 or the GLP-1 agonists, the human clinical evidence for Epithalon is almost entirely from Russian-language publications from a single research consortium (Khavinson / Anisimov / Korkushko). Western replication is minimal. The rodent data are real but modest: in female SHR mice, Epitalon left mean life span unchanged, raised the life span of the last 10% of survivors by 13.3% and maximum life span by 12.3%, and cut bone-marrow chromosome aberrations by 17.1% (PMID: 14501183). Translating that to human longevity remains a hypothesis rather than a demonstrated fact.

    Epithalon is used in biohacking communities for:

    • Sleep consolidation in adults over 40 (melatonin restoration)
    • Telomere preservation as part of a longevity stack
    • Circadian rhythm repair after shift-work or jet lag
    • Adjunct in age-related immunosenescence

    It is delivered by subcutaneous injection, typically 5-10 mg/day for 10-20 consecutive days, followed by a 3-6 month washout. This intermittent pulsing is intentional — Khavinson's protocols were always short-cycle, never continuous — and is a key safety feature in the absence of long-term continuous-dosing data.

    Epithalon is not approved by FDA or EMA. In the US it is sold by websites, several of which label it for research use only, and marketed by wellness clinics and concierge medicine practices. On 28 October 2026 HHS announced a draft interim policy covering epithalon, as epitalon acetate (FDA's spelling), for subcutaneous or intramuscular use in intermittent courses. Under it, HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities or licensed physicians that compound it under set conditions, including a single active ingredient per product. The policy is not an approval. An FDA advisory committee's July 2026 vote to recommend adding epithalon to the 503A bulks list of substances pharmacies may compound from, against the advice of FDA staff, is not binding.

    How it works

    Epithalon (AEDG; Ala-Glu-Asp-Gly) is a synthetic tetrapeptide modeled on the pineal polypeptide preparation epithalamin. Its proposed mechanism spans several parallel pathways. The human-relevant evidence is strongest for melatonin/circadian effects; the strongest laboratory evidence is the telomerase work in human cell culture.

    Read the full mechanismShow less

    1. Telomerase activation and telomere elongation (human cell culture)

    The most-cited finding is that Epithalon added to telomerase-negative human fetal fibroblasts induced expression of the telomerase catalytic subunit (hTERT), restored telomerase activity, and elongated telomeres ([PMID:12937682] - Khavinson, Bondarev & Butyugov, Bull Exp Biol Med, 2003). In a follow-up, fibroblasts that normally senesced at passage 34 underwent roughly 10 additional divisions (to passage ~44), overcoming the Hayflick limit, with telomeres re-lengthened toward early-passage size ([PMID:15455129] - Khavinson et al., Bull Exp Biol Med, 2004). These are in-vitro results in cultured cells; the peptide is not itself a telomerase enzyme and appears to de-repress the hTERT gene rather than encode it. (The figure often quoted online - a 33% telomere increase at 10 ng/mL over 10 days - is not stated in the primary papers and should not be treated as established.)

    2. Melatonin restoration via pineal signalling

    Epithalon derives from epithalamin, a pineal peptide preparation used in Soviet/Russian geriatric medicine since the 1970s. In a randomized controlled trial in elderly coronary patients, courses of epithalamin normalized the circadian rhythm of melatonin production and of carbohydrate/lipid metabolism ([PMID:22451889] - Korkushko, Khavinson et al., Bull Exp Biol Med, 2011). This melatonin/circadian normalization is the most plausible basis for the deeper, more consolidated sleep users report as the earliest subjective effect. Note that the human melatonin data derive chiefly from epithalamin (the parent preparation), not from the isolated AEDG tetrapeptide.

    3. Site-specific DNA / chromatin binding (proposed epigenetic modulation)

    Fluorescence and nuclear-penetration studies show AEDG enters the cell nucleus and binds single- and double-stranded DNA and deoxyribooligonucleotides in a sequence-specific manner, discriminating cytosine-methylation status and binding preferentially to CNG- and CAG-containing sequences ([PMID:22117547] - Fedoreyeva et al., Biochemistry (Mosc), 2011). This site-specific binding is proposed as an epigenetic route by which short peptides could influence gene activity. (Earlier claims that AEDG specifically targets "ACATAC/ATTTC" promoter motifs are not supported by this work.)

    4. Rodent life-span and tumor data - what it actually shows

    The Anisimov/Khavinson group tested Epitalon in several mouse strains, and the real effects are modest. In outbred Swiss-derived SHR mice, Epitalon did not change mean life span; it increased the life span of the last 10% of survivors by ~13% and maximum life span by ~12%, reduced bone-marrow chromosome aberrations by ~17%, and did not change total spontaneous tumor incidence, though it suppressed leukemia roughly 6-fold ([PMID:14501183] - Anisimov et al., Biogerontology, 2003). In CBA mice, chronic dosing modestly prolonged life span with a reduction in spontaneous tumor incidence ([PMID:11227856] - Anisimov et al., Ross Fiziol Zh, 2001). In senescence-accelerated (SAM) mice it lengthened survival among the longest-lived animals without changing overall tumor frequency ([PMID:15909815] - Anisimov et al., Vopr Onkol, 2005). These are genuine but modest, tail-of-survival effects - not the "~30% life-span extension" or "tumor incidence 44%23%" figures that circulate in vendor copy.

    What epithalon does NOT do

    • It is not a growth-hormone secretagogue and does not raise IGF-1 or drive muscle accretion (contrast CJC-1295/Ipamorelin).
    • It has no FDA- or EMA-approved indication, and Western human evidence is limited.
    • Its telomerase effect is promoter-level de-repression in cell culture, not a demonstrated systemic anti-aging effect in humans.

    Studied for

    • Longevity / anti-aging
    • Telomere biology
    • Chronobiology / sleep
    • Pineal endocrinology
    • Geroscience
    • Epigenetics
    • Cancer prevention (rodent)
    • Immunosenescence

    Benefits listed

    • Telomerase activation and telomere elongation (human cell culture)
    • Normalization of circadian melatonin rhythm (human data from epithalamin, the parent pineal preparation)
    • Improved sleep consolidation and circadian regularity (subjective)
    • Modest life-span effects in rodents (mainly maximum / late-survivor lifespan; no change in mean lifespan)
    Show 4 moreShow less
    • Reduced incidence of specific tumors (e.g. ~6-fold fewer leukemias in SHR mice); no change in total tumor incidence
    • Reduced chromosomal aberrations in aged rodent tissue
    • Site-specific DNA / chromatin binding (proposed epigenetic modulation)
    • Association with lower mortality in an elderly cardiovascular cohort (epithalamin RCT, Korkushko 2011)

    02Research

    Free with email

    What the research shows

    Graded on 2 research benches

    Reference pages that put Epithalon next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only.

    Unlock the research summary

    Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.

    • A summary of the key research
    • Safety and side effects
    • A link to the PubMed results

    You also get the free peptide cheat sheet by email. Unsubscribe anytime.

    Have an account? Sign in

    03Safety

    Epithalon side effects and interactions

    Side effects

    Common

    • Injection site redness or mild irritation (subcutaneous administration)
    • Mild drowsiness during evening administration (likely due to melatonin stimulation)
    • Transient flushing reported anecdotally

    Serious events

    • No serious adverse events reported in published literature
    • Long-term safety data limited to Russian bioregulation studies
    • Theoretical concern about telomerase activation in pre-cancerous cells (though animal data shows tumor suppression, not promotion)
    • No Western clinical trials conducted — all human data from Russian gerontological programs

    Who should not use it

    Contraindications

    Absolute contraindications

    • Active malignancy (any type) — hTERT upregulation is a theoretical pro-tumorigenic signal; avoid until complete remission with clinical clearance.
    • History of hormone-sensitive cancer (breast, prostate, endometrial) within 5 years — insufficient data to stratify risk; conservative approach is avoidance.
    • Pregnancy and lactation — no safety data.
    • Active immunosuppression (transplant medication, biologics) — unknown interaction with interferon-γ upregulation.
    • Active untreated autoimmune disease (lupus, rheumatoid arthritis, MS in flare) — theoretical risk of disease flare via Th1 potentiation; avoid until stable and discussed with rheumatologist.
    Read all the contraindications and cautionsShow less

    Relative contraindications

    • Remote hormone-sensitive cancer (>5 years remission) — discuss with oncologist; consider risk/benefit individually.
    • Psychiatric disorders with sleep-rhythm sensitivity (bipolar, cyclothymia) — melatonin amplification may destabilize mood cycles in rare cases.
    • Chronic kidney disease stage 4-5 — limited data on peptide clearance; use cautiously if at all.
    • Hemophilia or active anticoagulation — injection-site bleeding risk; use SC not IM, rotate sites.

    Drug interactions to be aware of

    • Exogenous melatonin — not a true interaction but additive sleep pressure; reduce melatonin dose 50% during epithalon cycles.
    • SSRIs / SNRIs — no pharmacokinetic interaction, but increased dream vividness may be bothersome.
    • Immunosuppressants — avoid or use under specialist supervision.
    • Chemotherapy / radiation therapy — concurrent use has no evidence base; avoid.

    Surgery and procedure considerations

    • Hold for 2 weeks pre-elective surgery (conservative; no actual bleeding concern demonstrated).
    • No pulse-oximetry interference (distinguishes from methylene blue).
    • Disclose use to all clinicians.

    What to disclose to any clinician

    • Dose, frequency, brand/vendor, COA availability
    • Cycle dates and duration
    • All concurrent supplements and peptides
    • Prior peptide history (lifetime exposure estimate)

    Interactions

    4 pairings in our record: 4 noted as compatible or synergistic. Compatible and synergistic are notes from the record, not safety findings.

    • GHK-Cu

      Synergistic

      Both have anti-aging mechanisms — telomere + skin rejuvenation

    • Thymosin Alpha-1

      Synergistic

      Immune modulation + telomere support for longevity protocols

    • MOTS-c

      Synergistic

      Mitochondrial + telomere anti-aging synergy

    • NAD+

      Synergistic

      NAD+ supports cellular energy while Epithalon supports telomere integrity

    This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

    Need bloodwork before starting?

    Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.

    Order Bloodwork

    04Dosing

    Free with email

    Epithalon dosage and protocols

    Dose range
    5000-10000 mcg (5-10 mg) subcutaneous daily for 10-20 day cycles; typically repeated 1-2 times per year in anti-aging protocols
    Dosing
    Once daily for 10–20 day cycles
    Common vials
    10mg, 50mg

    Unlock the dosing protocols

    Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.

    • Dose, route, how often and how long
    • A titration schedule
    • Beginner, intermediate and advanced protocols
    • Reconstitution and handling notes

    You also get the free peptide cheat sheet by email. Unsubscribe anytime.

    Have an account? Sign in

    05Prices

    Epithalon prices

    4 listings from 3 vendors, opening in the Featured order.

    Pack prices
    $34.99 to $79.99
    Lowest per mg
    $3.50/mg
    Vendors
    3
    Listings
    4 (vial, capsule)

    Prices as the vendors list them, last recorded 27 October 2026.

    Form
    Sort
    Epithalon listings, in Featured order
    VendorProductPriceBuy

    Epitalon 10 mg

    vial, 1 vial (10 mg)

    In stock

    $4.00/mg

    $39.99

    Buy Epitalon 10 mg at Disguised Alpha

    Capsulated Epitalon

    capsule, capsules

    In stock

    $79.99

    No mg count

    Buy Capsulated Epitalon at Disguised Alpha

    Epithalon 10mg

    vial, 1 vial

    In stock

    $3.75/mg

    $37.45

    Buy Epithalon 10mg at Limitless Biochem EU

    Epithalon 10mg

    vial, 10mg vial

    In stock

    $3.50/mg

    $34.99

    Lowest per mg
    Buy Epithalon 10mg at Half Nattys
    Vendors selling Epithalon(3: trust score, certificates, payment, shipping)

    Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. How we score these vendors

    Price history(4 days with a recorded price)
    Review Epithalon

    Sign in to leave a review

    Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Epithalon.

    06Chemistry

    Chemistry and structure

    Molecular formula
    C14H22N4O9
    Molecular mass
    390.35 g/mol
    CAS number
    307297-39-8
    IUPAC name
    L-alanyl-L-alpha-glutamyl-L-alpha-aspartylglycine
    Amino acid sequence
    Ala-Glu-Asp-Gly (AEDG)
    Half-life
    Not well characterized in humans. As a small tetrapeptide, AEDG is expected to have a very short plasma half-life (on the order of minutes), while downstream gene-expression and circadian effects are thought to persist considerably longer. Any specific half-life figure should be treated as an unvalidated estimate.
    View on PubChem

    08Questions

    Frequently asked questions

    How strong is the human evidence for epithalon's longevity claims?

    The rodent data is real but modest: across SHR, CBA and SAM mouse strains, Epitalon mainly extended maximum and late-survivor lifespan (roughly 10-13% in the last 10% of survivors) rather than mean lifespan, reduced certain tumors (about 6-fold fewer leukemias in SHR mice) without lowering total tumor incidence, and cut chromosome aberrations - it did not produce the ~30% lifespan jumps sometimes claimed online. The human data are almost entirely from one Russian/Ukrainian group and largely use epithalamin (the parent pineal preparation), not the isolated AEDG tetrapeptide; the most-cited is a randomized controlled study in elderly coronary patients (Korkushko/Khavinson 2011) reporting decelerated cardiovascular aging, normalized melatonin rhythm and significantly lower mortality. No Western double-blind RCT exists. Treat epithalon as plausible-but-unproven for human longevity endpoints, and at best suggestive for sleep and melatonin support in older adults.

    Will I notice anything during my first cycle?

    The most reliable subjective effect is deeper, more consolidated sleep starting around night 3-5 of a cycle. Many users report more vivid dreams in the first week (consistent with restored REM pressure from melatonin rise). Energy and mood improvements in the day typically lag sleep changes by a week or so. If you are under 40 with already-good sleep, the effect may be subtle. If you are over 50 with age-related sleep fragmentation, the effect is usually obvious by the end of week 2.

    How often should I cycle epithalon?

    Standard Russian protocol: 10-20 consecutive days, then a minimum of 3 months off. Most biohackers run 1-2 cycles per year separated by ~6 months. The most-cited elderly trial (Korkushko/Khavinson) actually used the parent preparation epithalamin as 6 courses over 3 years with long-term follow-up, not continuous dosing. Continuous daily dosing is not evidenced and is contrary to every published protocol; the pulsed pattern is thought to matter, letting the pineal axis re-regulate rather than downregulate under sustained stimulation.

    Is epithalon safe for someone with a history of cancer?

    It is an absolute contraindication during active malignancy and a relative contraindication for at least 5 years after hormone-sensitive cancer (breast, prostate, endometrial). The mechanism - hTERT upregulation via promoter demethylation - is theoretically pro-tumorigenic, even though rodent data paradoxically show reduced incidence of certain tumors (possibly via immune rejuvenation). Without human data to stratify this risk, the conservative approach is to avoid. Survivors of long-remission non-hormone-sensitive cancers should discuss individually with an oncologist.

    Can I take epithalon orally instead of injection?

    Oral delivery is not expected to work: AEDG is a short peptide rapidly hydrolyzed by gastric and intestinal proteases. Sublingual delivery has been used in people: FDA's 2026 review of epitalon found three published human studies, two of them sublingual in night-shift workers and the third a parabulbar injection in retinitis pigmentosa. FDA found no pharmacokinetic data for epitalon by any route, so no route has a published bioavailability figure. Subcutaneous injection is the route the compounding nominations proposed, not the route the published human studies used. HHS's October 2026 draft interim compounding policy also covers only subcutaneous or intramuscular epitalon.

    What is the difference between epithalon and epithalamin?

    Epithalamin is the crude bovine pineal extract used in Soviet/Russian geriatric medicine from the 1970s onward - a mixture of many pineal peptides. Epithalon (AEDG) is the synthetic four-amino-acid tetrapeptide that Khavinson identified as the active fragment. Epithalon is purer, more consistent, and easier to dose; epithalamin is rarely used today outside specific Russian clinical contexts. When biohackers say 'epithalon,' they almost always mean the synthetic tetrapeptide.

    Can I stack epithalon with other peptides like BPC-157 or CJC-1295?

    Yes, with two caveats. First, isolate variables in your first epithalon cycle - you want to know what epithalon does to your sleep before introducing another variable. Second, combining with a GH secretagogue (CJC-1295, ipamorelin) or healing peptide (BPC-157) has no documented pharmacologic interaction but lacks controlled safety data in combination. Most users run epithalon as a twice-yearly standalone cycle and use other peptides continuously in the intervening months. See our Peptide Stacking Guide for structured combinations.

    Do I need a telomere length test to benefit from epithalon?

    No. Telomere length assays (Life Length, Telomere Diagnostics, SpectraCell) have significant methodological variability - same-day duplicate samples can differ 10-20% - and no clinical guideline supports using them to make peptide decisions. If you want to track telomere length for curiosity or longitudinal self-quantification, do it consistently with the same lab and same assay; expect noisy data. The best proximate biomarker for whether epithalon is working for you is objective sleep data (deep sleep minutes, HRV, sleep efficiency) from an Oura or Whoop.

    Why is epithalon not FDA-approved?

    A 2026 review found no adequately powered randomized trial showing a clinical benefit (PMID: 42884164), and FDA's 2026 review found three published studies that gave epitalon to people. Most published work comes from one group in Russia: Khavinson is an author of 106 of the 168 PubMed records on the peptide (search run 2 November 2026). The result is a peptide studied mainly in Russia and approved in neither the US nor the EU. In the US it is sold as a research chemical. A draft interim policy HHS announced on 28 October 2026 also covers epitalon acetate compounded by state-licensed pharmacies, federal facilities or licensed physicians for subcutaneous or intramuscular use under set conditions; that policy is not an approval. This is why vendor-grade material should always be sourced with a valid COA and handled as a research chemical.

    How many vendors sell Epithalon, and what does it cost per mg?

    3 of the vendors BodyHackGuide tracks list Epithalon (4 listings). Among BodyHackGuide's Epithalon listings recorded as in stock with a milligram count, the lowest price per milligram is $3.50/mg at Half Nattys and the median is $3.75/mg. The Epithalon prices on BodyHackGuide are vendors' listed prices as BodyHackGuide last recorded them, not transactions; the most recent recorded change to a Epithalon listing is dated 27 October 2026.

    Which vendors have third-party COAs for Epithalon on file at BodyHackGuide?

    BodyHackGuide holds 1 third-party certificate record for Epithalon, from Optimum Formula. An editor has read the one of BodyHackGuide's certificate records for Epithalon and recorded the laboratory, the compound and the test date as printed on each. The laboratory named on BodyHackGuide's Epithalon certificate record is Janoshik Analytical, and the test date on it is 1 March 2026. Each vendor page on BodyHackGuide shows how many certificate records BodyHackGuide holds for that vendor and links to each record that has its own page.

    Related

    Articles on Epithalon

    Free 2026 Peptide Cheat Sheet (PDF)

    38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.

    Download Free